Lomé, August 12, 2026 — The stark choice facing West Africa is clear: either continue importing pharmaceuticals at scale or build a self-sufficient health industry from the ground up. This decisive moment brought together medical professionals, academics, and researchers from across the subregion on August 12 at Lomé’s Agora Senghor, where they laid the groundwork for a complete overhaul of West Africa’s health strategy.
The 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference did more than just echo calls for increased funding. The gathering of the region’s future healthcare leaders demanded nothing short of a paradigm shift. The outdated model of pharmacies as mere distribution points is being consigned to history. In its place, the focus is shifting toward industrialization, genomic research, and the scientific validation of traditional knowledge.
Local production: a cornerstone of national security
The global pandemic and subsequent supply chain disruptions served as a wake-up call for the continent. Dependence on imported medicines is no longer just an economic anomaly—it represents a critical vulnerability in national security. This was the central argument advanced during the summit.
Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s bold new direction under President Faure Essozimna Gnassingbé: making local pharmaceutical innovation and production the region’s primary defense against future health crises. To achieve this, the state is committing to substantial investment in scientific cooperation and applied research.
Genomic epidemiology and indigenous wisdom: the pillars of a new approach
Local production alone is insufficient if it merely replicates foreign patents. True sovereignty lies in tailoring treatments to Africa’s unique genetic and epidemiological landscape. By placing genomic epidemiology at the heart of discussions, the Lomé conference highlighted an urgent scientific priority: developing therapies based on the genetic makeup of African populations, who have long been underrepresented in global clinical trials.
This cutting-edge scientific vision is being paired with a bold cultural reappraisal. Experts are advocating for the industrialization of traditional medicine. The shift isn’t about tolerating informal herbal practices—it’s about subjecting them to rigorous clinical trials to identify and patent entirely new active molecules rooted in African heritage.
Redefining the role of pharmacists in West Africa
Yet this industrial and scientific ambition faces a critical challenge: human capital. As the sector evolves, so too must academic training. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, identified the linchpin of this transformation: curriculum reform. The pharmacist of tomorrow cannot be trained simply to dispense medication behind a counter. Instead, they must emerge as a cutting-edge researcher, a key player in manufacturing, and an expert in validating indigenous knowledge systems.
As discussions in Lomé enter their final phase, the objective of the 21st FESPAO conference is unambiguous: transform these academic debates into enforceable public policy proposals. The goal? To ensure universal healthcare access in West Africa is no longer contingent on factories situated thousands of kilometers from patients.
The stakes could not be higher. Without a robust local pharmaceutical industry and research infrastructure rooted in African realities, West Africa will remain dependent on external solutions. In the face of future pandemics, this dependence could prove costly in terms of lives lost. True health sovereignty will be measured by each nation’s ability to turn these resolutions into tangible actions—ensuring every patient has access to care designed, validated, and produced on African soil.
